Refractory Epstein-Barr Virus (EBV)-related post-transplant lymphoproliferative disease : cure by combined brentuximab vedotin and allogeneic EBV-specific T-lymphocytes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in medicine, 6, Artikel 295, S. 295-1-295-5
- Event
-
Veröffentlichung
- (where)
-
Bochum
- (who)
-
Ruhr-Universität Bochum
- (when)
-
2019
- Creator
-
Mika, Thomas
Strate, Katharina
Ladigan, Swetlana
Aigner, Clemens
Schlegel, Uwe
Tischoff, Iris
Tischer-Zimmermann, Sabine
Eiz-Vesper, Britta
Maecker-Kolhoff, Britta
Schroers, Roland
- URN
-
urn:nbn:de:hbz:294-77480
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mika, Thomas
- Strate, Katharina
- Ladigan, Swetlana
- Aigner, Clemens
- Schlegel, Uwe
- Tischoff, Iris
- Tischer-Zimmermann, Sabine
- Eiz-Vesper, Britta
- Maecker-Kolhoff, Britta
- Schroers, Roland
- Ruhr-Universität Bochum
Time of origin
- 2019
Other Objects (12)
Endoscopic detection of an early manifestation of EBV-related post-transplant lymphoproliferative disorder in a transplanted colon
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors : A Case Report
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
Post-transplant Epstein–Barr Virus-Related Lymphoproliferative Disorder: A Case Report and Review of Literature
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
Frequenz und Phänotyp Epstein-Barr Virus (EBV)-spezifischer T-Lymphozyten im Verlauf asymptomatischer EBV-Reaktivierungen gesunder Virusträger
Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact
Endoscopic detection of an early manifestation of EBV-related post-transplant lymphoproliferative disorder in a transplanted colon
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors : A Case Report
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
Post-transplant Epstein–Barr Virus-Related Lymphoproliferative Disorder: A Case Report and Review of Literature
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
Frequenz und Phänotyp Epstein-Barr Virus (EBV)-spezifischer T-Lymphozyten im Verlauf asymptomatischer EBV-Reaktivierungen gesunder Virusträger
Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact
Endoscopic detection of an early manifestation of EBV-related post-transplant lymphoproliferative disorder in a transplanted colon
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors : A Case Report
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
Post-transplant Epstein–Barr Virus-Related Lymphoproliferative Disorder: A Case Report and Review of Literature
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study
CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
Frequenz und Phänotyp Epstein-Barr Virus (EBV)-spezifischer T-Lymphozyten im Verlauf asymptomatischer EBV-Reaktivierungen gesunder Virusträger